Xiaohan Li
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Circular RNAs in diseases 6
- Gut microbiota and health 4
-
- Cancer-related molecular mechanisms research 5
- MicroRNA in disease regulation 3
- Co-authors
- Bing Xia (2 shared papers)Beita Zhao (2 shared papers)Rong-Wei Kou (2 shared papers)Renjie Shi (2 shared papers)Xiaoning Liu (2 shared papers)Li Zhang (1 shared paper)Zhigang Liu (1 shared paper)Ai-Xia Liu (1 shared paper)
- Journals
- Plant Communications (2 papers)Drug Design Development and Therapy (2 papers)Cell Death Discovery (1 paper)Cellular Signalling (1 paper)Antioxidants and Redox Signaling (1 paper)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Xiaohan Li
33 papers receiving 488 citations
Xiaohan Li's Hit Papers
Peers
Comparison fields: 5 of 90
- Biological Psychiatry 15
- Cancer Research 70
- Behavioral Neuroscience 14
- Biochemistry 26
- Molecular Biology 218
Countries citing papers authored by Xiaohan Li
This map shows the geographic impact of Xiaohan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaohan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaohan Li more than expected).
Fields of papers citing papers by Xiaohan Li
This network shows the impact of papers produced by Xiaohan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaohan Li. The network helps show where Xiaohan Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaohan Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 94 | |
| 2 | 2018 | 46 | |
| 3 | 2014 | 41 | |
| 4 | 2022 | 39 | |
| 5 | 2022 | 34 | |
| 6 | 2024 | 27 | |
| 7 | 2018 | 26 | |
| 8 | 2020 | 22 | |
| 9 | Predicting 28-day all-cause mortality in patients admitted to intensive care units with pre-existing chronic heart failure using the stress hyperglycemia ratio: a machine learning-driven retrospective cohort analysis Hit paper breakdown → | 2025 | 21 |
| 10 | 2022 | 20 | |
| 11 | 2020 | 17 | |
| 12 | 2024 | 15 | |
| 13 | 2022 | 15 | |
| 14 | The clinicopathological and prognostic significance of MUC-1 expression in Japanese gastric carcinomas: an immunohistochemical study of tissue microarrays. | 2008 | 11 |
| 15 | 2014 | 10 | |
| 16 | 2016 | 6 | |
| 17 | [The distribution and antimicrobial resistance tendency of pathogens associated with diarrhea in Beijing]. | 2008 | 5 |
| 18 | 2022 | 4 | |
| 19 | 2024 | 4 | |
| 20 | 2022 | 4 |
About Xiaohan Li
Xiaohan Li is a scholar working on Molecular Biology, Cancer Research, Pathology and Forensic Medicine, Food Science and Surgery, having authored 45 papers that have together received 493 indexed citations. Recurring topics across this work include Circular RNAs in diseases (6 papers), Cancer-related molecular mechanisms research (5 papers), Gut microbiota and health (4 papers), MicroRNA in disease regulation (3 papers), Probiotics and Fermented Foods (3 papers), Cancer Mechanisms and Therapy (2 papers), Alzheimer's disease research and treatments (2 papers) and Hyperglycemia and glycemic control in critically ill and hospitalized patients (2 papers). The work is most often cited by research in Biological Psychiatry (15 citations), Cancer Research (70 citations), Behavioral Neuroscience (14 citations), Biochemistry (26 citations) and Molecular Biology (218 citations). Xiaohan Li has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Bing Xia, Beita Zhao, Rong-Wei Kou, Renjie Shi, Xiaoning Liu, Li Zhang, Zhigang Liu, Ai-Xia Liu, Huan Wang and Jiaqi Li. Their work appears in journals such as Plant Communications, Drug Design Development and Therapy, Cell Death Discovery, Cellular Signalling and Antioxidants and Redox Signaling.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.